Article Text

Download PDFPDF
Small animal disease surveillance: gastrointestinal disease, antibacterial prescription and Tritrichomonas foetus
  1. David A. Singleton,
  2. Elena Arsevska,
  3. Steven Smyth,
  4. Emily N. Barker,
  5. Christopher Jewell,
  6. Bethaney Brant,
  7. Fernando Sánchez-Vizcaíno,
  8. Susan Dawson,
  9. Gina L. Pinchbeck,
  10. Peter J.M. Noble,
  11. Philip H. Jones and
  12. Alan D. Radford
  1. Institute of Infection and Global Health
  2. Institute of Veterinary Science, University of Liverpool, Leahurst Campus, Neston CH64 7TE, UK
  3. Langford Vets
  4. Bristol Veterinary School, University of Bristol, Langford Campus, Bristol BS40 5DU, UK
  5. Lancaster Medical School, Lancaster University, Furness Building, Lancaster LA1 4YG, UK
  6. Surveillance Intelligence Unit, Animal and Plant Health Agency, Kendal Road, Harlescott, Shrewsbury SY1 4HD, UK
  1. Correspondence to Dr Singleton, e-mail: D.A.Singleton{at}

Statistics from

Gastrointestinal disease, antibacterial prescription and Tritrichomonas foetus: Report summary

  • Presentation for investigation and/or treatment of gastrointestinal (GI) disease comprised 3.0 per cent, 2.0 per cent and 1.9 per cent of total dog, cat and rabbit consultations, respectively, between 1 April 2017 and 31 October 2018.

  • Diarrhoea and vomiting without blood were the most frequently reported GI disease clinical signs (43.0 and 36.6 per cent in dogs, and 35.9 and 37.7 per cent in cats, respectively).

  • The proportion of GI disease consultations during which antibiotics authorised for systemic administration (including oral and injectable formulations) were prescribed decreased between April 2014 and October 2018.

  • The proportion of GI disease consultations during which nutraceutical products advertised as being effective at managing primary GI disease (including prebiotics, probiotics, etc) were dispensed increased between April 2014 and October 2018.

  • Between January 2011 and August 2018, 13.5 per cent of 20,194 feline faecal samples submitted to UK-based diagnostic laboratories tested positive for the presence of Tritrichomonas foetus.

  • The proportion of feline sample submissions testing positive for T foetus decreased between 2011 and 2018.

Syndromic surveillance of gastrointestinal disease

This report represents the third time the Small Animal Veterinary Surveillance Network (SAVSNET) has summarised gastrointestinal (GI) disease in companion animals.1,2 The present report considers electronic health records (EHRs) captured by the SAVSNET project from 236 voluntary veterinary practices (526 sites) over a 19-month period from 1 April 2017 to 31 October 2018. A detailed description of the methodology used by SAVSNET to capture EHRs has been provided previously.2,3

A total of 2,231,928 consultations were analysed, of which 69.8 per cent were from dogs, 26.8 per cent were from cats, 1.7 per cent were from rabbits, and the remaining 1.6 per cent were from other species, or where species was not recorded. Animals mainly presenting for investigation and/or treatment of GI disease according to the attending veterinary surgeon or …

View Full Text


  • Dr Arsevska’s present address is CIRAD, Research Unit ASTRE, Campus International de Baillarguet, Montpellier, France

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.